Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemofiltration in diabetic uremic patients.

G P Segoloni, A Pacitti, G Squiccimarro

    The International Journal of Artificial Organs
    |January 1, 1983
    PubMed
    Summary

    Hemofiltration (HF) offers promising results for Diabetic Uremic Patients (DUP) undergoing substitutive treatment (ST). This study shows HF improves vascular stability and hypertension control, presenting a viable alternative to C.A.P.D.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

    Physical review letters·2026
    Same author

    First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

    Physical review letters·2026
    Same author

    Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

    Physical review letters·2026
    Same author

    Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

    Physical review letters·2026
    Same author

    Observation of tWZ Production at the CMS Experiment.

    Physical review letters·2026
    Same author

    Black Hole Spectroscopy and Tests of General Relativity with GW250114.

    Physical review letters·2026

    Area of Science:

    • Nephrology
    • Diabetology
    • Internal Medicine

    Background:

    • Diabetic Uremic Patients (DUP) present unique challenges for substitutive treatment (ST).
    • Continuous Ambulatory Peritoneal Dialysis (C.A.P.D.) is well-documented, but Hemofiltration (HF) is less explored for DUP.
    • Existing ST options for DUP often yield disappointing clinical results and side effects.

    Purpose of the Study:

    • To evaluate the potential of Hemofiltration (HF) as a substitutive treatment (ST) for Diabetic Uremic Patients (DUP).
    • To assess the clinical outcomes and feasibility of postdilutional HF in a cohort of DUP.

    Main Methods:

    • Retrospective analysis of data from 6 DUP treated with postdilutional HF.
    • Multi-center data collection over a 10.6 months/patient period.

    Related Experiment Videos

  • Evaluation of key clinical parameters including vascular stability, blood pressure, retinopathy, complications, and hospitalization.

    • Main Results:

    • HF treatment demonstrated good vascular stability in DUP.
    • Effective control of arterial hypertension and retinopathy was observed.
    • Reduced clinical complications and hospitalization rates were noted with HF therapy.
    • HF showed potential in managing DUP when C.A.P.D. is unmanageable.

    Conclusions:

    • Hemofiltration (HF) is a viable and effective substitutive treatment (ST) option for Diabetic Uremic Patients (DUP).
    • HF offers significant benefits in managing hypertension, retinopathy, and overall clinical stability.
    • HF can serve as a valuable alternative or adjunct to C.A.P.D. for DUP, ensuring continuous treatment.